4 - 10 November 2017
These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts
Mavenclad made available quickly in England
NHS England has negotiated with the manufacturer of Mavenclad (cladribine) so that people eligible for treatment can access the drug "immediately". Mavenclad was approved by NICE on 2 November.
MS Trust link: Mavenclad (cladribine) available immediately in England for highly active relapsing multiple sclerosis - MS Trust news item